ResMed | RMD - Loan Capital

Stock Price
216.85
Daily Change
-5.17 -2.33%
Monthly
-1.45%
Yearly
-8.79%
Q2 Forecast
215.15

ResMed reported $403.92M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Ansell USD 751.6M 113.1M Dec/2025
Artivion USD 217.81M 2.94M Dec/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Cochlear AUD 200M 6.5M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
CSL USD 10.42B 273M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Fisher Paykel Healthcare NZD 62.6M 4.3M Dec/2025
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 919.99M 406K Dec/2025
Idexx Laboratories USD 374.84M 17K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Philips EUR 6.93B 303M Dec/2025
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
ResMed USD 403.92M 4.74M Dec/2025
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.9B 1.1M Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026